Performance evaluation of Espline HTLV-I/II, a newly developed rapid immunochromatographic antibody test for different diagnostic situations.

HTLV-1 immunochromatographic antibody test point-of-care test sensitivity specificity

Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
15 Nov 2023
Historique:
medline: 15 11 2023
pubmed: 15 11 2023
entrez: 15 11 2023
Statut: aheadofprint

Résumé

The World Health Organization estimated that 5-10 million people are infected with human T-cell leukemia virus type 1 (HTLV-1). This number is likely to be underestimated because reliable endemic data are available for only approximately 1.5 billion people worldwide. The point-of-care test is a powerful tool for the easy and quick detection of infections without the requirement for expensive instruments and laboratory equipment. Espline HTLV-I/II, a newly developed rapid immunochromatographic antibody test that was evaluated in this study, might significantly advance our understanding of the global epidemiology of HTLV-1 infection.

Identifiants

pubmed: 37966220
doi: 10.1128/spectrum.02078-23
pmc: PMC10715220
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0207823

Références

J Clin Microbiol. 2017 Sep;55(9):2838-2849
pubmed: 28701419
J Med Virol. 2008 Mar;80(3):484-93
pubmed: 18205214
PLoS Negl Trop Dis. 2018 Oct 12;12(10):e0006832
pubmed: 30312301
Front Microbiol. 2012 Nov 15;3:388
pubmed: 23162541
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9
pubmed: 6261256
Blood. 1995 Aug 15;86(4):1392-9
pubmed: 7632947
Vox Sang. 2015 Aug;109(2):122-8
pubmed: 25930000
Gan. 1984 Oct;75(10):845-8
pubmed: 6096197
J Ocul Pharmacol Ther. 2017 May;33(4):216-223
pubmed: 28263674
J Infect Dis. 2023 Mar 28;227(6):752-760
pubmed: 35867855
Lancet. 1986 May 3;1(8488):1031-2
pubmed: 2871307
Ann Neurol. 2001 Dec;50(6):807-12
pubmed: 11761481
Science. 1989 Apr 28;244(4903):471-5
pubmed: 2655084
Int J Cancer. 2012 May 15;130(10):2318-26
pubmed: 21780105
PLoS Negl Trop Dis. 2018 Oct 25;12(10):e0006833
pubmed: 30359373
J Clin Microbiol. 2017 Jul;55(7):2180-2187
pubmed: 28468860
Blood. 1990 Aug 1;76(3):450-4
pubmed: 2378978
Ann Neurol. 2004 Jul;56(1):10-9
pubmed: 15236397
Front Immunol. 2023 Feb 03;14:1043600
pubmed: 36817417
Diagn Microbiol Infect Dis. 2010 May;67(1):61-9
pubmed: 20227221
J Clin Microbiol. 2012 May;50(5):1663-72
pubmed: 22403426
J Med Virol. 2017 Aug;89(8):1469-1476
pubmed: 28252206
AIDS Rev. 2004 Jul-Sep;6(3):144-54
pubmed: 15595431
Science. 1982 Nov 5;218(4572):571-3
pubmed: 6981847
Transfusion. 2021 Feb;61(2):484-493
pubmed: 33368334
Blood. 2005 Oct 1;106(7):2462-71
pubmed: 15956280
Retrovirology. 2020 Aug 24;17(1):26
pubmed: 32831150
N Engl J Med. 2019 Jan 17;380(3):296-298
pubmed: 30650320
J Clin Virol. 2023 Jul;164:105446
pubmed: 37148674
Proc Natl Acad Sci U S A. 1982 Mar;79(6):2031-5
pubmed: 6979048
Bull World Health Organ. 1991;69(1):127-9, 131-3
pubmed: 2054916

Auteurs

Madoka Kuramitsu (M)

Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo, Japan.

Haruka Momose (H)

Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo, Japan.

Yuichiro Uchida (Y)

Department of Hematology and Rheumatology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Kenji Ishitsuka (K)

Department of Hematology and Rheumatology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Ryuji Kubota (R)

Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.

Masahito Tokunaga (M)

Department of Hematology, Imamura General Hospital, Kagoshima, Japan.

Atae Utsunomiya (A)

Department of Hematology, Imamura General Hospital, Kagoshima, Japan.

Kunihiko Umekita (K)

Division of Respirology, Rheumatology, Infectious Diseases and Neurology, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan.
Department of Clinical Laboratory, University of Miyazaki Hospital, Miyazaki, Japan.

Yuuki Hashikura (Y)

Department of Clinical Laboratory, University of Miyazaki Hospital, Miyazaki, Japan.

Kisato Nosaka (K)

Cancer Center, Kumamoto University Hospital, Kumamoto, Japan.

Ki-Ryang Koh (K-R)

Department of Hematology, Osaka General Hospital of West Japan Railway Company, Osaka, Japan.

Hitomi Nakamura (H)

Japanese Red Cross Kyushu Block Blood Center, Fukuoka, Japan.

Yasuko Sagara (Y)

Japanese Red Cross Kyushu Block Blood Center, Fukuoka, Japan.

Rieko Sobata (R)

Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.

Masahiro Satake (M)

Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.

Koh Nagata (K)

Department of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Yuri Hasegawa (Y)

Department of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Daisuke Sasaki (D)

Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.

Hiroo Hasegawa (H)

Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.

Tomoo Sato (T)

Department of Neurology, St. Marianna University School of Medicine, Kanagawa, Japan.
Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa, Japan.

Yoshihisa Yamano (Y)

Department of Neurology, St. Marianna University School of Medicine, Kanagawa, Japan.
Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa, Japan.

Kou Hiraga (K)

Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo, Japan.

Kenta Tezuka (K)

Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo, Japan.

Emi Ikebe (E)

Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo, Japan.

Sahoko Matsuoka (S)

Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo, Japan.

Kazu Okuma (K)

Department of Microbiology, Faculty of Medicine, Kansai Medical University, Osaka, Japan.

Toshiki Watanabe (T)

Laboratory of Practical Management of Medical Information, Graduate School of Medicine, St. Marianna University, Kanagawa, Japan.

Kiyonori Miura (K)

Department of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Isao Hamaguchi (I)

Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo, Japan.
Department of Clinical Laboratory, Subaru Health Insurance Society Ota Memorial Hospital, Gunma, Japan.

Classifications MeSH